Identifying Outcomes of Patients With Advanced Pancreatic Adenocarcinoma and RECIST Stable Disease Using Radiomics Analysis.

Qiuxia YangYize MaoHui XieTao QinZhijun MaiQian CaiHailin WenYong LiRong ZhangLi-Zhi Liu

Published in: JCO precision oncology (2022)

RS independently predicts the outcomes of patients with SD after chemotherapy well and can help to improve treatment decisions by identifying patients for whom current treatment may not be suitable.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
combination therapy
magnetic resonance
computed tomography
peritoneal dialysis
adipose tissue
locally advanced
insulin resistance
lymph node metastasis
replacement therapy
rectal cancer
patient reported outcomes
weight loss